Researchers at the University of Pittsburgh have developed a new antibody-type therapy for SARS-CoV-2, the causative virus for COVID-19. The treatment exploits “nanobodies” – tiny antibody fragments – that are harvested from llama blood. The new nanobody therapy can be used in an inhalable form that may deactivate the virus within the lungs.
(Read more...)